Journey Medical DERM
NASDAQ DERM
$7.61 -0.36 (-4.52%)
As of: Sep 9, 2026 · 1:23 PM EDT

Journey Medical (DERM) Other Non-Current Assets (2020 - 2024)

Journey Medical's (DERM) quarterly Other Non-Current Assets came in at $6000.0 in Q3 2024, little changed on a YoY basis from $6000.0 in Q4 2023, and little changed quarter-over-quarter from $6000.0 in Q2 2024.

Analysis

Journey Medical (DERM) Other Non-Current Assets (2020 - 2024) Analysis & Trends

Journey Medical (DERM) has reported Other Non-Current Assets for 5 consecutive years, with $6000.0 the latest figure, recorded in Q3 2024.

  • For the quarter ending Q3 2024, Other Non-Current Assets changed 0.0% year-over-year to $6000.0; the trailing twelve-month figure through Sep 2024 stood at $6000.0 (changed 0.0% YoY), and the FY2023 full-year result was $6000.0, down 93.68% from the prior year.
  • Other Non-Current Assets was little changed at $6000.0 in Q3 2024 per DERM's latest filing, from $6000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $8.8 million in Q1 2023 and bottomed at $6000.0 in Q4 2020.
  • Historically, Other Non-Current Assets has averaged $726214.3 across 5 years, with a median of $50500.0 in 2020.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets surged 7357.63% in 2023, then tumbled 99.93% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $6000.0 in 2020, then soared by 2400.0% to $150000.0 in 2021, then tumbled by 36.67% to $95000.0 in 2022, then sank by 93.68% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $6000.0, $6000.0, and $6000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn 14.27 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn 10.73 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn 5.93 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 9.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 5.50 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn - 42.45 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 86.76 Mn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 239.50 Mn
10 Journey Medical 209.23 Mn 183.58 Mn 12.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 6,000.00
Jun 30, 2024 6,000.00
Mar 31, 2024 6,000.00
Dec 31, 2023 6,000.00
Sep 30, 2023 6,000.00
Jun 30, 2023 6,000.00
Mar 31, 2023 8.80 Mn
Dec 31, 2022 95,000.00
Sep 30, 2022 103,000.00
Jun 30, 2022 110,000.00
Mar 31, 2022 118,000.00
Dec 31, 2021 150,000.00
Sep 30, 2021 749,000.00
Dec 31, 2020 6,000.00